Saturday, July 11, 2026

pharma · Levodopa-Induced Dyskinesia

Xinhua Hospital, Shanghai

Xinhua Hospital, Shanghai clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
1
Drugs
3
Patents
0
Intelligence · Clinical Programs

Xinhua Hospital, Shanghai projects

1 ClinicalTrials.gov programs sponsored by Xinhua Hospital, Shanghai.

Xinhua Hospital, Shanghai has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Tianqi Pingchan Granule

    Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

    Levodopa-Induced Dyskinesia

    small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Xinhua Hospital, Shanghai have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.